…s relatively rare (<3% at 30 days, even for older patients with frailty),5 6 other adverse patient prioritised outcomes are relatively …
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 16 of 2459… Reviews and Meta-Analyses (PRISMA) checklist.22Definitions The National Cancer Institute defines polygenic risk scores as an assessment of the risk for …
…an in SjD (p<0.0001). Sicca symptoms were more prevalent in SSc/SjD compared to SSc (p<0.0001). Interstitial lung disease (ILD) was…
…g studies of populations with wide age ranges most informative. Colorectal cancer is a notable exception, with persistent increases limited to yo…
…ity and median household income were negatively associated with T1DM incidence.28Subgroup analyses revealed that both sexes experien…
…ological pathways linking metals, clinical factors, and diet to diabetes risk Multiple, non-mutually exclusive pathways may explain how …
…ng either cisplatin, docetaxel and 5-fluorouracil or cisplatin, docetaxel and capecitabine, followed by surgery and adjuvant radiotherapy…
… therapeutic positioning.Aim and Objectives To evaluate whether pembrolizumab, dostarlimab, durvalumab, durvalumab plus olaparib, and atezoli…
…Objectives Both lupus nephritis (LN) and ANCA-vasculitis are associated with an increased infec…
…erceived self-efficacy were significantly associated with lower prediabetes prevalence and 2h-PG levels among men, but not among women.Figu…
…iated with a numerically lower risk of worsening HF compared to gabapentin users (HR 0.71, 95% CI 0.09-5.43) (figure 1). Overall, the dire…